PMA supplement
P940011 S001: COHERENT PDL1 AND PDL2 LAMBDA PLUS PHOTODYNAMIC LASERS
FDA PMA supplement · Normal 180 Day Track · Lumenis, Inc.
Key facts
| Original PMA | P940011 |
|---|---|
| Supplement number | S001 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Labeling Change - Indications/instructions/shelf life/tradename |
| Trade name | COHERENT PDL1 AND PDL2 LAMBDA PLUS PHOTODYNAMIC LASERS |
| Applicant | Lumenis, Inc. |
| Received date | Feb 14, 1997 |
| Decision date | Jan 9, 1998 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: